Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | -75,000 | net | 07 Feb 2025 | tx 8+5,239,994−5,314,994 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 3,000,000 | 0.03 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 2,000,000 | 0.05 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 314,994 | 0.45 SEK | |
| 31 May 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 2,000,000 | 0.03 SEK | deriv |
| 20 Mar 2023 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 3,000,000 | 0.06 SEK | deriv |
| 07 Jul 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 165,910 | 0.35 SEK | |
| 28 Jun 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 49,084 | 0.35 SEK | first after silence |
| 15 Feb 2019 | PURCHASE | NeuroVive Pharmaceutical AB | 25,000 | 1.35 SEK |
1 purchase reported after at least 12 months of silence — most recent on 28 Jun 2022.